Department of Neurosurgery, Fudan University Shanghai Cancer Center, and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Department of Neurosurgery, Fudan University Shanghai Cancer Center, and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
World Neurosurg. 2019 Aug;128:62-68. doi: 10.1016/j.wneu.2019.02.223. Epub 2019 Apr 4.
Preoperative embolization (POE) of meningioma has been established to facilitate surgical resection, which may reduce intraoperative blood loss and surgical time. However, no consensus has been achieved in meningioma treatment and no meta-analysis has been conducted. The purpose of this study was to perform a systematic review and meta-analysis and provide evidence of the efficacy of meningioma treatment with POE and direct surgery.
This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. A systematic search was performed using PubMed and EMBASE. Meta-analysis was performed using the risk ratio of overall complication, mean difference (MD) of blood loss, and surgical time. The I statistic was used to assess the heterogeneity.
Eight studies (1 randomized controlled trial and 7 non-randomized controlled trials) were included, in which 510 patients met the inclusion criteria. We found that preoperative embolization for patients with meningioma did not increase the overall complication rate (risk ratio = 0.92, 95% confidence interval [CI] 0.61-1.38) and can significantly reduce intraoperative blood loss (MD = -65.10, 95% CI -124.76 to -20.82) and surgical time (MD = -38.48, 95% CI -64.03 to -12.93) compared with the control patients. No significant publication bias was observed.
This meta-analysis supports the hypothesis that POE of meningioma is a useful adjunct in meningioma treatment. This technique helps reduce blood loss and surgical time during meningioma resection.
脑膜瘤的术前栓塞(POE)已被确立为促进手术切除的方法,这可能减少术中失血量和手术时间。然而,在脑膜瘤的治疗中尚未达成共识,也没有进行荟萃分析。本研究的目的是进行系统评价和荟萃分析,为脑膜瘤的 POE 和直接手术治疗提供疗效证据。
本系统评价按照系统评价和荟萃分析的首选报告项目进行。使用 PubMed 和 EMBASE 进行系统搜索。使用总并发症的风险比、失血量的均数差(MD)和手术时间进行荟萃分析。使用 I ²统计量评估异质性。
纳入了 8 项研究(1 项随机对照试验和 7 项非随机对照试验),其中 510 名患者符合纳入标准。我们发现,脑膜瘤患者的术前栓塞并未增加总并发症发生率(风险比=0.92,95%置信区间 [CI] 0.61-1.38),并可显著减少术中失血量(MD=-65.10,95%CI-124.76 至-20.82)和手术时间(MD=-38.48,95%CI-64.03 至-12.93)与对照组相比。未观察到显著的发表偏倚。
这项荟萃分析支持脑膜瘤 POE 是脑膜瘤治疗中有用的辅助手段的假设。该技术有助于减少脑膜瘤切除术中的失血量和手术时间。